{"id":2064,"date":"2024-04-16T12:55:04","date_gmt":"2024-04-16T12:55:04","guid":{"rendered":"https:\/\/stoxpo.com\/?p=2064"},"modified":"2024-04-16T12:55:06","modified_gmt":"2024-04-16T12:55:06","slug":"palisade-bio-reports-promising-results-for-uc-treatment-pali-2108","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/","title":{"rendered":"Palisade Bio Reports Promising Results for UC Treatment PALI-2108"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Successful Analysis Demonstrates Effective Bioactivation of Colon-Specific PDE4 Inhibitor Prodrug<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Palisade Bio (PALI), a biopharmaceutical firm dedicated to advancing therapies for autoimmune, inflammatory, and fibrotic diseases, announces positive outcomes from its analysis of PALI-2108, an oral colon-specific phosphodiesterase-4 (PDE4) inhibitor prodrug for ulcerative colitis (UC) patients.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The study, conducted in collaboration with Altasciences, confirms PALI-2108&#8217;s efficient conversion into its active form within stool samples from both healthy individuals and UC patients. LC-MS analysis revealed a mean conversion rate of 90.1% within a 24-hour timeframe, signaling the drug&#8217;s potential efficacy in managing UC.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Mitch Jones, Palisade Bio&#8217;s CMO, expresses confidence in PALI-2108 as a targeted UC therapy, emphasizing its consistent and robust bioactivation profile. These findings underscore the drug&#8217;s promise as an innovative treatment option for moderate-to-severe UC, offering hope for patients seeking effective disease management strategies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read original press release:<a href=\"https:\/\/finance.yahoo.com\/news\/palisade-bio-successfully-demonstrates-bioactivation-123000686.html\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">here<\/mark><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2024\/04\/15\/lockheed-martin-secures-17-billion-contract-for-next-gen-interceptors\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Lockheed Martin Secures $17 Billion Contract for Next-Gen Interceptors<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Successful Analysis Demonstrates Effective Bioactivation of Colon-Specific PDE4 Inhibitor Prodrug Palisade Bio (PALI), a biopharmaceutical firm dedicated to advancing therapies for autoimmune, inflammatory, and fibrotic diseases, announces positive outcomes from its analysis of PALI-2108, an oral colon-specific phosphodiesterase-4 (PDE4) inhibitor prodrug for ulcerative colitis (UC) patients. The study, conducted in collaboration with Altasciences, confirms PALI-2108&#8217;s [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1422,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"1","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[358,309],"tags":[],"coauthors":[453],"class_list":["post-2064","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-micro-cap","category-pharmaceuticals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Palisade Bio Reports Promising Results for UC Treatment PALI-2108 - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Palisade Bio Reports Promising Results for UC Treatment PALI-2108 - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Successful Analysis Demonstrates Effective Bioactivation of Colon-Specific PDE4 Inhibitor Prodrug Palisade Bio (PALI), a biopharmaceutical firm dedicated to advancing therapies for autoimmune, inflammatory, and fibrotic diseases, announces positive outcomes from its analysis of PALI-2108, an oral colon-specific phosphodiesterase-4 (PDE4) inhibitor prodrug for ulcerative colitis (UC) patients. The study, conducted in collaboration with Altasciences, confirms PALI-2108&#8217;s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-16T12:55:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-16T12:55:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liliana Vida\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liliana Vida\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/\"},\"author\":{\"name\":\"Liliana Vida\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\"},\"headline\":\"Palisade Bio Reports Promising Results for UC Treatment PALI-2108\",\"datePublished\":\"2024-04-16T12:55:04+00:00\",\"dateModified\":\"2024-04-16T12:55:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/\"},\"wordCount\":167,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"articleSection\":[\"Micro-Cap\",\"Pharmaceuticals\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/\",\"name\":\"Palisade Bio Reports Promising Results for UC Treatment PALI-2108 - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"datePublished\":\"2024-04-16T12:55:04+00:00\",\"dateModified\":\"2024-04-16T12:55:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"radiology-2\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/16\\\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Palisade Bio Reports Promising Results for UC Treatment PALI-2108\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\",\"name\":\"Liliana Vida\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"caption\":\"Liliana Vida\"},\"description\":\"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/stoxpo-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Palisade Bio Reports Promising Results for UC Treatment PALI-2108 - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/","og_locale":"en_US","og_type":"article","og_title":"Palisade Bio Reports Promising Results for UC Treatment PALI-2108 - Stoxpo","og_description":"Successful Analysis Demonstrates Effective Bioactivation of Colon-Specific PDE4 Inhibitor Prodrug Palisade Bio (PALI), a biopharmaceutical firm dedicated to advancing therapies for autoimmune, inflammatory, and fibrotic diseases, announces positive outcomes from its analysis of PALI-2108, an oral colon-specific phosphodiesterase-4 (PDE4) inhibitor prodrug for ulcerative colitis (UC) patients. The study, conducted in collaboration with Altasciences, confirms PALI-2108&#8217;s [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/","og_site_name":"Stoxpo","article_published_time":"2024-04-16T12:55:04+00:00","article_modified_time":"2024-04-16T12:55:06+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","type":"image\/jpeg"}],"author":"Liliana Vida","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liliana Vida","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/"},"author":{"name":"Liliana Vida","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1"},"headline":"Palisade Bio Reports Promising Results for UC Treatment PALI-2108","datePublished":"2024-04-16T12:55:04+00:00","dateModified":"2024-04-16T12:55:06+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/"},"wordCount":167,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","articleSection":["Micro-Cap","Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/","url":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/","name":"Palisade Bio Reports Promising Results for UC Treatment PALI-2108 - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","datePublished":"2024-04-16T12:55:04+00:00","dateModified":"2024-04-16T12:55:06+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","width":2560,"height":1707,"caption":"radiology-2"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/16\/palisade-bio-reports-promising-results-for-uc-treatment-pali-2108\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Palisade Bio Reports Promising Results for UC Treatment PALI-2108"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1","name":"Liliana Vida","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6","url":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","caption":"Liliana Vida"},"description":"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/stoxpo-com\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2064","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=2064"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2064\/revisions"}],"predecessor-version":[{"id":2065,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2064\/revisions\/2065"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1422"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=2064"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=2064"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=2064"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=2064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}